光热治疗
光动力疗法
光敏剂
纳米颗粒
叶酸受体
体内
材料科学
联合疗法
纳米技术
化学
癌症
癌细胞
光化学
药理学
医学
有机化学
生物技术
内科学
生物
作者
Weiwei Zeng,Hanjie Zhang,Yimin Deng,Aiting Jiang,Xiaoyan Bao,Minqi Guo,Zimu Li,Meiying Wu,Xiaoyuan Ji,Xiaowei Zeng,Lin Mei
标识
DOI:10.1016/j.cej.2020.124494
摘要
Photonic therapy (e.g., photodynamic therapy (PDT) and photothermal therapy (PTT)), features easy handling, good targeting, high curative effect and lower side effects compared to other treatments, thus showing considerable potential in cancer treatment. However, adverse tumor microenvironment, low light conversion efficiency, and inherent toxicity of photonic agents limit their further application in clinic. In this work, hollow mesoporous MnO2 nanoparticles (NPs) loaded with photosensitizer chlorin e6 and coated with folic acid-functionalized polydopamine were fabricated, and used as a platform for photonic therapy. The NPs enabled accurately controlled drug release, and sustainable and extensive O2 production by reacting with endogenous H2O2 in vitro. In addition, the NPs allowed efficient NIR light-to-heat conversion, owing to the core-shell MnO2/polydopamine structure. With the synergy of folic acid mediated active targeting and enhanced permeability and retention effect mediated passive targeting, a pronounced NPs accumulation at the tumor sites of mouse model was observed. The NPs also exhibited excellent biodegradation properties, alleviating the possible concerns about the long-term safety of photonic agents. Finally, a combination of O2-strengthened PDT and PTT resulted in effective tumor growth inhibition upon irradiation with 660 nm and 808 nm laser in vivo treatment. The above features of the devised NPs highlight their potential for improved cancer therapy and imaging.
科研通智能强力驱动
Strongly Powered by AbleSci AI